SUSAN GREINER: Open Payments
NPI 1851466825 · EAST CHINA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,630 in 70 payments from 24 companies in 2025. Trend: 2023 $1,530 · 2024 $1,460 · 2025 $1,630
Food & beverage: $1,531Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $217 |
| Olympus America Inc. | 15 | $195 |
| BIOTISSUE HOLDINGS INC. | 1 | $157 |
| PFIZER INC. | 6 | $147 |
| Sumitomo Pharma America, Inc. | 6 | $143 |
| Antares Pharma, Inc. | 5 | $117 |
| ABBVIE INC. | 5 | $101 |
| Verity Pharmaceuticals Inc. | 3 | $61 |
| UROGEN PHARMA, INC. | 2 | $58 |
| Procept Biorobotics Corporation | 2 | $56 |
Products named: ERLEADA, Xtandi, iTIND System, XYOSTED, GEMTESA, BOTOX, JELMYTO, AQUABEAM ROBOTIC SYSTEM.
Industry payments across MI — which companies pay providers there.
